** Shares of investment management co Challenger CEL.AX
drop as much as 8.8% to A$5.59, their lowest levels since
January 28, 2022
** Co posts HY normalised NPAT of A$225 million ($142.94
million), lower than consensus estimate of A$229 million,
according to Jefferies
** Total sales for co's core Life segment fall 12% in HY;
Life normalised EBIT misses expectations
** Declares interim dividend of 14.5 Australian cents per
share, higher than consensus estimates of 13.8 cents
** CGF stock is worst performer on ASX 200 benchmark index
.AXJO
** Stock down 4.7% YTD, including day's moves
($1 = 1.5741 Australian dollars)
(Reporting by Himanshi Akhand in Bengaluru)
((Himanshi.Akhand@thomsonreuters.com;))